Fulgent Genetics, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
CEO Ming Hsieh reports a change in beneficial ownership of Fulgent Genetics common stock following equity award vesting.
NASDAQ
Fulgent Genetics CEO Ming Hsieh and his Trust updated their beneficial ownership, revealing equity award vestings, tax-related sales, and significant share pledges.